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H
ip and knee osteoarthritis (OA) is a major cause of 
musculoskeletal pain and disability.17,20 Primary symptoms 
of hip OA include pain, stiffness, and activity limitations.16,23 
Several studies have investigated impairments and function 
in patients with hip OA, such as lower extremity muscle strength,1,40,44 
hip range of motion (ROM),2,43 and aerobic capacity.38,41 Most of the 
Karin rydeviK, PT, MSc1  •  Linda Fernandes, PT, MSc2  •  Lars nordsLetten, MD, PhD3  •  May arna risberg, PT, PhD4
1 Physical Therapist, Norwegian Research Center for Active Rehabilitation (NAR), Department of Orthopedics, Oslo University Hospital and Hjelp24 Norwegian Sports Medicine 
Clinic (Hjelp24 NIMI), Oslo, Norway. 2 PhD student, NAR, Department of Orthopedics, Oslo University Hospital and Hjelp24NIMI Norwegian Sports Medicine Clinic (Hjelp24 NIMI), 
Oslo, Norway. 3 Professor, Department of Orthopedics, Oslo University Hospital and University of Oslo, Oslo, Norway. 4 Professor and Chair, NAR, Norwegian School of Sport 
Sciences, Department of Orthopedics, Oslo University Hospital and Hjelp24NIMI Norwegian Sports Medicine Clinic (Hjelp24 NIMI), Oslo, Norway. Research ethics approval was 
obtained from the Regional Committee of Medical Research Ethics and the Norwegian Data Inspectorate (Institutional Review Board). Address correspondence to Karin Rydevik, 
Hjelp24NIMI, Sognsveien 75 D, 0805 Oslo, Norway. E-mail: karin.rydevik@hjelp24.no
Functioning and Disability in  
Patients With Hip Osteoarthritis  
With Mild to Moderate Pain
t stUdy design: Cross-sectional study.
t obJeCtiVe: To compare functioning and dis-
ability in patients with hip osteoarthritis (OA) not 
candidates for surgery, to a matched control group, 
and thereby to examine the relationship between 
the functioning and disability components used in 
this study in patients with hip OA.
t baCKgroUnd: It is well know that patients 
with severe hip OA have deficits in functioning 
and disability. However, in patients with hip OA not 
candidates for surgery, the knowledge regarding 
functioning and disability is sparse.
t MetHods: Twenty-six patients (12 men, 14 
women; mean age, 60 years) with radiographic 
and symptomatic hip OA were matched to 26 
controls without hip pain. The following variables 
were measured: muscle strength using isokinetic 
peak force, hip passive range of motion, submaxi-
mal aerobic capacity using a cycling test, walking 
ability using the 6-minute walk test, self-reported 
pain, stiffness, and physical function using the 
Western Ontario and McMaster University Osteo-
arthritis Index, and health-related quality of life 
using the SF-36.
t resULts: The patients with hip OA had mild 
to moderate pain, as indicated by the Western On-
tario and McMaster University Osteoarthritis Index, 
and significantly lower knee extension strength 
(mean difference [95% confidence interval {CI}]: 
–19.5 [–34.3, –4.7] Nm). Hip range of motion was 
significantly less in the patients with hip OA, with 
mean (95% CI) differences of –10° (–14°, –6°) for 
extension, –18° (–26°, –11°) for flexion, –9° (–14°, 
–4°) for abduction, –2° (–5°, 0°) for adduction, 
–16° (–23°, –9°) for internal rotation, and –21° 
(–28°, –14°) for external rotation. The patients with 
hip OA walked a significantly shorter distance in 
6 minutes (mean difference, –75 m; 95% CI: –131, 
–20 m). There were no significant differences in hip 
extension/flexion, knee flexion, ankle dorsiflexion/
plantar flexion muscle strength, or aerobic capac-
ity between the 2 groups. There were significant 
associations between body function and activity 
components.
t ConCLUsion: Physical therapists should 
consider including quadriceps-strengthening and 
hip range-of-motion exercises when developing 
rehabilitation programs for patients with hip OA, 
with mild to moderate pain, aiming to improve 
functioning and reduce disability. J Orthop Sports 
Phys Ther 2010;40(10):616-624. doi:10.2519/
jospt.2010.3346
t Key Words: aerobic capacity, muscle strength, 
quality of life, range of motion, walking distance
studies have included patients with se-
vere radiographic and symptomatic hip 
OA who were candidates for total hip 
replacement (THR) surgery.38,40,41 How-
ever, data indicate that only 12% of the 
patients seeking help for hip pain end-
ed up having THR within 3 years and 
22% within 6 years.29 The patient group 
not candidates for surgery represents, 
therefore, the majority of patients seek-
ing primary care for hip pain, including 
patients with hip OA. Two studies have 
investigated muscle strength in patients 
with less-severe hip OA and found lower 
hip flexion1 and knee extension strength44 
compared to matched controls. However, 
only 1 of these 2 studies investigated mus-
cle strength in patients with hip OA com-
pared to matched control subjects.1 While 
other studies have compared muscle size 
and muscle strength of the affected com-
pared to the unaffected limb,40,44 it has 
been shown that muscle function is of-
ten affected in the healthy limb.8 Hence, 
there is a lack of information available 
regarding functioning and disability in 
patients with hip OA not candidates for 
surgery, compared to a matched control 
group. Increased knowledge in this field 
would be of major importance both for 
clinicians performing physical examina-
tion and when developing active rehabili-
tation programs to improve functioning 
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reliability for the WOMAC.42
The Physical Activity Score for Elder-
ly30 was used to quantify level of physical 
activity, including frequency and dura-
tion of strength training.
Control group
Twenty-six controls without hip pain 
(12 men and 14 women; mean  SD 
age, 59.7  10.4 years) were matched 
to the patients with hip OA based on 
age (5 years), gender, and amount of 
strength training (frequency and dura-
tion) according to the last question in 
the Physical Activity Score for Elderly.30 
Inclusion criteria were no history of hip 
pain and a HHS above 95 points. The 
subjects in the control group were re-
cruited from the local area, and through 
patients’ friends and by colleagues. For 
isokinetic muscle strength tests and 
ROM tests, the same side as the pa-
tients involved hip joint was matched 
to the controls’ hip. Both the patients 
with hip OA and the controls were ex-
cluded if they had any history of recent 
trauma or functional impairment in the 
lower extremity, or diseases that might 
interfere with participation in the study 
(eg, rheumatoid arthritis, cancer, osteo-
porosis, severe back pain, knee pain, or 
knee OA). Subjects with comorbidities 
not tolerating physical activity were 
excluded.
Research ethics approval was obtained 
from The Regional Committee of Medi-
cal Research Ethics and the Norwegian 
Data Inspectorate. All subjects signed an 
informed consent.
Measurements
We used parts of the International Clas-
sification of Functioning, Disability, and 
Health (ICF)46 framework to list the mea-
surements of functioning and disability 
into (1) body function and (2) activity. 
Applying the ICF to OA, hip OA can lead 
to impairments of body function and ac-
tivity limitations.
Measurements of iCF body Function
Isokinetic Muscle Strength Test Peak 
torque for hip and knee flexion and 
extension and ankle dorsiflexion and 
plantar flexion were tested using an iso-
kinetic machine (REV 9000; Technogym 
SpA, Gambettola, Italy) set at 60°/s. The 
test protocol included a warm-up of 4 
repetitions, followed by a 20-second rest 
prior to 5 repetitions of maximal muscle 
strength. The highest peak torque value 
of the 5 repetitions was used in both 
groups, and the isokinetic device was 
calibrated prior to every test. Isokinet-
ic knee extension and flexion muscle 
strength tests were performed with the 
subject in a sitting position, with fixa-
tion over trunk and thigh. The knee joint 
testing range was set to 5° to 85° knee 
flexion. Knee isokinetic peak torque 
measurements at this angular velocity 
have been shown to have high reliability, 
with an intraclass correlation coefficient 
(ICC) of 0.91 for subjects without pain 
and for different age groups.12 Isokinetic 
ankle dorsiflexion and plantar flexion 
muscle strength tests were performed 
with the subject in supine, the hip and 
knee joints extended, and the limb fixed. 
The ankle joint testing range was set at 
5° dorsiflexion to 40° plantar flexion. 
Measurements of ankle isokinetic muscle 
strength in supine (30°/s, peak torque), 
have moderate to low intrarater reliabil-
ity for plantar flexion (ICC = 0.53-0.72) 
and dorsiflexion (ICC = 0.20-0.49).36 
Measurements of hip extension and 
flexion strength were performed with the 
subjects in supine, with fixation over the 
pelvis. The hip joint testing range was set 
at 35° to 75° hip flexion, and the opposite 
limb was fixed, with the hip and knee ex-
tended. Measurements of hip flexion and 
extension strength (60°/s, peak torque) 
in supine have shown moderate to high 
reliability for patients with hip OA (ICC 
= 0.84-0.87).1
Range of Motion Joint ROM was mea-
sured using a half-circle 1°-increment 
plastic goniometer with a moveable arm. 
Hip flexion, adduction, and abduction 
were measured in supine, with the op-
posite thigh fixed in neutral position.37 
Internal and external rotation of the hip 
and reduce symptoms in patients with 
hip OA. The aim of the present study 
was, therefore, to evaluate functioning 
and disability in terms of lower extremity 
muscle strength, hip ROM, walking dis-
tance, aerobic capacity, and health quality 
of life in patients with hip OA compared 
to a matched control group. An addi-
tional aim was to examine the relation-
ship between functioning and disability 




wenty-six patients with hip OA 
(12 men and 14 women) between 40 
and 80 years of age (mean  SD, 
60.3  11.5), with bilateral or unilateral 
radiographic and symptomatic hip OA, 
were recruited consecutively from a ran-
domized clinical trial carried out at Oslo 
University Hospital, Norway. For patients 
with bilateral hip OA (n = 15), the most 
painful hip was selected for analysis. In-
clusion criteria were hip pain for more 
than 3 months, radiographically verified 
reduced minimal joint space according 
to Danielsson criteria,15 and Harris Hip 
Score (HHS) (score range, 0-100) be-
tween 60 and 95 points.25 At our insti-
tution a HHS below 60 points has been 
used for decades as a criterion for patients 
with hip OA who are candidates for THR. 
The radiographic evaluation was made by 
a senior orthopaedic surgeon (L.N.), and 
the clinical examination, including the 
HHS, was completed by a senior physi-
cal therapist (L.F.). Self-reported pain, 
joint stiffness, and physical function were 
registered using the Western Ontario 
and McMaster University Osteoarthritis 
Index (WOMAC VA3.1).7 The WOMAC 
(score range, 0-100) is a self-adminis-
tered and disease-specific instrument 
specially designed for patients with hip or 
knee OA. To categorize the patient’s pain 
level we used the WOMAC pain subscale 
(10 to 40, mild pain; greater than 40 to 
60, moderate pain; greater than 60 to 
100, severe pain).27 Psychometric studies 
have shown moderate to high validity and 
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were measured in prone, with the hip ex-
tended and the knee in 90° flexion.37 Hip 
extension was measured using the modi-
fied Thomas test.18,37 Measuring hip ROM 
in patients with hip OA, using a goniom-
eter, has shown to have a high intrarater 
reliability (ICC = 0.82-0.95), except for 
adduction (ICC = 0.50-0.72).13,26
Aerobic Capacity Subjects were tested 
using a submaximal ergometer cycle test. 
The cycle test was also used as a warm-up 
prior to performing the isokinetic muscle 
strength tests. Predicted maximal aerobic 
capacity was calculated according to the 
nomogram described by Astrand.5 The 
load and sitting position were adjusted 
to each subject and the ergometer cycle 
was calibrated to kilopascal (kPa) prior 
to each test. Heart rate was corrected 
for age,3 gender, and body mass, and ex-
pressed in ml/kg  min. The nomogram 
for calculation of the maximal aerobic ca-
pacity has shown to be valid for healthy 
subjects (age, 20-50 years), when the re-
sults are corrected for age (r = 0.76-0.92; 
ICC = 0.94).14,45 We calculated age, cor-
recting factor for subjects above 69 years 
of age (n = 10), because the nomogram 
lacks age corrections for that age range.
Measurements of iCF activity
Six-Minute Walk Test (6MWT) All sub-
jects were asked to walk as far as pos-
sible during 6 minutes by walking back 
and forth in a 20-m long corridor.19 The 
walking distance was registered in meters 
using a tape measure, and the time was 
monitored with a stopwatch. Immedi-
ately after, the test subjects were asked to 
score hip pain during walking on a visual 
analog scale ranging from 0 to 100 mm, 
where 0 represented no pain and 100 ex-
treme pain. The 6MWT has been shown 
to have high intrarater reliability (ICC = 
0.94) in patients with hip OA.28
Health-Related Quality of Life The self-
administered generic 36-item short-form 
health survey (SF-36, v2) was completed 
by both the patients with hip OA and 
the controls. The SF-36 has shown to be 
reliable and valid for both physical and 
mental health.33,34 The SF-36 consists of 
8 subscales: physical function, role limi-
tations due to physical problems, bodily 
pain, and general health perceptions, and 
role limitations due to emotional prob-
lems, mental health, social functioning, 
and vitality. Each score ranges from 0 to 
100, were 0 is the poorest possible health 
state and 100 is the best health state. 
The physical function subscale score was 
used to examine the relationship between 
body function and activity components.
statistical analysis
Sample size was based on a priori pow-
er calculations.31 The primary outcome 
measure was isokinetic knee extension 
peak torque values, with estimation of 
150 (36) Nm for subjects without hip 
OA and 105 (37) Nm for patients with 
hip OA.32 Based on 5% significance level 
and 90% power, 17 subjects were needed 
to be included in each group. If a subject 
in 1 of the 2 groups dropped out from a 
test, the matched pair was excluded. We 
included 26 subjects per group to make 
sure that we had enough power, consid-
ering the risk of pairs dropping out. The 
data were analyzed using SPSS Version 
15.0 (SPSS, Inc, Chicago, IL). The paired 
Student t test was used to evaluate dif-
ferences between the groups for nor-
mally distributed data, and the Wilcoxon 
rank sum test was used for nonnormally 
distributed data. Correlation analyses 
were performed with patients with hip 
OA, between body function and activi-
tabLe 1 Characteristics of Patients With Hip OA and Matched Controls
Abbreviations: HHS, Harris Hip Score; OA, osteoarthritis; PASE, modified version of Physical Activity Score for Elderly; WOMAC, Western Ontario and Mc-
Master University Osteoarthritis Index.
* Data presented as mean  SD.
 Patients With Hip oa (n = 26)* Controls (n = 26)* Mean difference (95% Ci) P Value
Age (y) 60.3  11.5 59.7  10.4 0.6 (–0.8, 12.0) .396
Height (m) 1.73  0.09 1.72  0.11 –0.01 (–0.5, 0.4) .740
Body mass (kg) 73.9  10.9 71.7  14.2 2.2 (–3.3, 7.6) .426
Body mass index (kg/m2) 24.6  2.9 24.0  3.3 –6.6 (–2.6, 1.3) .493
Men/women (n) 12/14 12/14  1.000
HHS (0-100) 76.3  7.9 99.5  1.2 23.2 (20.0, 26.4) .001
PASE (0-315) 112.5  50.4 137.0  43.7 –24.4 (–56.1, 7.3) .125
Strength training frequency score (0-4.3) (PASE) 2.5  4.8 2.1  3.5 0.5 (–4.8, 1.4) .327
Duration of pain (y) 2.3  1.5   
Bilateral/unilateral (n) 15/11   
Minimal joint space (mm) 2.0  1.1   
WOMAC pain (0-100) 30.8  16.3   
WOMAC stiffness (0-100) 35.3  19.0   
WOMAC physical function (0-100) 28.2  16.2   
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istics are presented in tabLe 1. The 
patients with hip OA had a mean 
 SD duration of pain of 2.5  1.5 years, 
minimal joint space of 2  1 mm, and 
scores on 3 subscales of the WOMAC 
of 30.8  16.3 for pain, 35.3  19.0 for 
stiffness, and 28.2  16.2 for physical 
function (tabLe 1). A flow chart is in-
cluded and pairs of missing values are 
ties components, using a Speareman 
rho correlation coefficient. Results were 
regarded as significant at P.05. The re-
sults were presented as mean, standard 
deviation, mean differences, and 95% 
confidence interval (CI).
Assessed for eligibility (n = 52) 
Patients with hip OA (n = 26) Matched controls (n = 26)
Matched on age, sex, 




• Knee flexion/extension (n = 26) 
• Hip flexion/extension (n = 26)
• Ankle plantar/dorsiflexion 
(n = 22)
Muscle strength:





• Ankle plantar/dorsiflexion 
Muscle strength:
• Knee flexion/extension 
(n = 25 pairs)
dorsiflexion (n = 20 pairs)
• Hip flexion/extension
(n = 24 pairs)
• Ankle plantar/ 
Reason for missing data: 
technical problems with the 
testing equipment (n = 4) Reason for missing data: 
technical problems with the 
testing equipment (n = 2)
6MWT (n = 26) 6MWT (n = 25)
Reason for missing data: 
pain in the lower extremity 
between the tests (n = 1)
6MWT (n = 25 pairs)
Aerobic capacity test (n = 24)
Reason for missing data: 
arrhythmic heart rate and 
pain in lower extremity 
between tests (n = 2)
Aerobic capacity test (n = 25)
Reason for missing data: 
pain in the lower extremity 
between the tests (n = 1)
Aerobic capacity test 
(n = 23 pairs)
ROM (n = 26) ROM (n = 26)ROM (n = 26 pairs)
FigUre. Study flowchart showing inclusion of subjects and measurements and analysis in matched pairs.
Abbreviations: 6MWT, 6-minute walk test; OA, osteoarthritis; ROM, range of motion.
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0°) for adduction, –16° (–23°, –9°) for 
internal rotation, and –21° (–28°, –14°) 
for external rotation (tabLe 3). Walking 
distance was significantly shorter dur-
ing the 6MWT in patients with hip OA 
compared to matched controls (mean 
difference, –75 m; 95% CI: –131, –20 
m). Furthermore, the patients with hip 
OA reported significantly higher mean 
 SD pain intensity (visual analog scale, 
18  17) during the 6MWT, compared to 
the matched controls, who reported no 
pain (tabLe 4). No significant difference 
in aerobic capacity was found between 
the 2 groups (tabLe 4). The health-relat-
ed quality of life was significantly lower 
among the patients with hip OA com-
pared to the matched controls for 6 of 8 
subscales of the SF-36 (tabLe 5). There 
were significant associations between 
body function and activity components. 
Muscle strength correlated significantly 
with walking distance (ρ = 0.48 to 0.64). 
Hip ROM for abduction and flexion 
correlated significantly with WOMAC 
physical function (ρ = –0.44 and –0.64, 
respectively). Hip flexion ROM corre-
lated significantly with walking distance 
(ρ = 0.52). WOMAC pain score was cor-
related with WOMAC physical function 
score (ρ = 0.67), and pain during wak-
ing was correlated with WOMAC physi-
presented (FigUre). The patients with hip 
OA had significantly lower peak torque 
for knee extension compared to the 
matched controls: mean difference (95% 
CI) of –19.5 (–34.3, –4.7) Nm (tabLe 2). 
There were no significant differences be-
tween groups for hip extension or flex-
ion, knee flexion, ankle dorsiflexion, or 
plantar flexion muscle strength (tabLe 2). 
There were significant differences in hip 
ROM between the 2 groups: mean (95% 
CI) difference was –10° (–14°, –6°) for 
extension, –18° (–26°, –11°) for flexion, 
–9° (–14°, –4°) for abduction, –2° (–5°, 
tabLe 3
Hip ROM for Patients With Hip OA  
and Matched Controls
Abbreviations: CI, confidence interval; OA, osteoarthritis; ROM, range of motion.
* Data presented as mean  SD degrees.
 oa (n = 26)* Control (n = 26)* Mean difference (95% Ci) P Value
Extension 1  10 11  5 –10 (–14, –6) <.001
Flexion 121  16 139  8 –18 (–26, –11) <.001
Abduction 24  11 33  8 –9 (–14, –4) .002
Adduction 25  7 27  5 –2 (–5, 0) .085
Internal rotation 30  14 46  12 –16 (–23, –9) <.001
External rotation 26  12 47  11 –21 (–28, –14) <.001
tabLe 4
6MWT and Aerobic Capacity in Patients  
With Hip OA and Matched Controls
Abbreviations: 6MWT, 6-minute walk test; CI, confidence interval; OA, osteoarthritis.
* Data presented as mean  SD.
† Visual analogue scale, 0-100 mm.
 Patients With Hip oa* Controls* Mean difference (95% Ci) P Value
6MWT (25 pairs), m 643  122 719  117 –75 (–131, –20) .010
Pain while walking (25 pairs)† 18  17 0  0 18 (11, 25) .001
Aerobic capacity (23 pairs), ml/kg  min 28  8 31  7 –2 (–6, 2) .257
tabLe 2
Isokinetic Peak Torque (Nm and Nm/BM) at 60°/s  
in Patients With Hip OA and Matched Controls
Abbreviations: BM, body mass; CI, confidence interval; OA, osteoarthritis.
* Data presented as mean  SD.
 Patients With Hip oa* Controls* Mean difference (95% Ci) P Value
Knee extension (25 pairs), Nm 112.8  40.6 132.4  48.6 –19.5 (–34.3, –4.7) .012
Knee extension (25 pairs), Nm/BM 1.5  0.4 1.8  0.4 –0.3 (–0.5, –0.1) .003
Knee flexion (25 pairs), Nm 69.5  32.2 71.7  31.6 –2.2 (–14.4, 10.0) .714
Knee flexion (25 pairs), Nm/BM 0.9  0.3 1.0  0.3 –0.1 (–0.2, 0.1) .445
Ankle dorsiflexion (20 pairs), Nm 67.1  25.0 66.6  24.3 –0.5 (–8.7, 9.7) .911
Ankle dorsiflexion (20 pairs), Nm/BM 0.9  0.3 0.9  0.2 0.0 (–0.1, 0.1) .948
Ankle plantar flexion (20 pairs), Nm 21.6  6.0 22.1  7.5 –0.5 (–2.9, 2.0) .703
Ankle plantar flexion (20 pairs), Nm/BM 0.3  0.1 0.3  0.1 –0.0 (–0.0, 0.0) .627
Hip extension (24 pairs), Nm 150.3  68.8 161.3  66.4 –11.0 (–33.1, 11.2) .317
Hip extension (24 pairs), Nm/BM 2.0  0.7 2.2  0.7 –0.2 (–0.5, 0.0) .177
Hip flexion (24 pairs), Nm 94.8  38.4 95.5  36.9 –0.7 (–15.1, 13.8) .920
Hip flexion (24 pairs), Nm/BM 1.3  0.4 1.3  0.4 –0.0 (–0.2, 0.2) .700
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cal function score and SF-36 physical 
function score (ρ = 0.44 and –0.51, re-
spectively). WOMAC stiffness correlat-
ed significantly with WOMAC physical 
function (ρ = 0.81) and with walking dis-
tance (ρ = –0.49). Aerobic capacity did 
not correlate to any activity components 
(ρ = 0.11 to –0.23) (tabLe 6).
disCUssion
t
his study reports significant-
ly lower knee extension muscle 
strength (15%) in patients with hip 
OA, not candidates for surgery, compared 
to matched controls. We also found sig-
nificantly lower hip ROM and shorter 
walking distance for the patients with 
hip OA compared to the matched con-
trols. The patients with hip OA in this 
study were categorized as having mild 
to moderate hip pain on the WOMAC 
pain subscale (minimum-maximum, 
5.2-59.4).27 Despite the mild to moderate 
pain reported by the patients with hip 
OA, they had significantly lower scores 
on the physical functioning and role limi-
tations physical subscales of the SF-36, 
compared to the matched control group.
Earlier studies have reported higher 
knee extension muscle strength deficits 
(20%-29%) in patients with hip OA com-
pared to our study.40,44 But these studies 
have included patients presurgery, with 
an average HHS of 52.6 (9.2).40,44 Addi-
tionally, both Rasch et al40 and Suetta et 
al44 used the contralateral side as the con-
trol limb for their patients with unilateral 
hip OA. Other studies have previously 
shown that, for patients with unilateral 
pathologies, strength of the contralateral 
side of an affected limb is also affected 
and may, therefore, not be optimal as a 
control limb.8 Consequently, we used a 
group of matched controls for the com-
parison. We also matched the groups 
based on strength training frequency, to 
ensure that the potential difference in 
muscle strength between groups would 
not be due to higher strength training fre-
quency in one of the groups. Our controls 
showed isokinetic knee extension peak 
torque values similar to those reported 
in previous studies of healthy men and 
women (130  25 Nm, 1.68  0.3 Nm/
BW).6,22 This indicates that our controls 
were representative of normative quad-
riceps strength data. In contrast to other 
studies, we found no significant differ-
ences in muscle strength for knee flexion 
or hip extension or flexion.1,40,44 But the 
tabLe 5
The 8 Subscales of the Health-Related  
Quality of Life Questionnaire, the SF-36, in 
Patients With Hip OA and Matched Controls*
Abbreviations: CI, confidence interval; OA, osteoarthritis; SF-36, 36-item short-form health survey.
* Each score ranges from 0-100, where 0 is the poorest possible health state and 100 is the best health state.
† Data presented as mean  SD.
 Patients With  Controls Mean difference 
 Hip oa (n = 26)†  (n = 26)† (95% Ci) P Value
Physical functioning 67  14 97  3 –30 (–35, –24) <.001
Role limitations due to physical problems 69  25 97  10 –28 (–39, –16) <.001
Body pain 53  16 94   9 –40 (–47, –34) <.001
General health 59  19 86  15 –27 (–37, –18) <.001
Vitality 52  19 75  14 –22 (–32, –12) <.001
Role limitations due to emotional problems 90  16 95  13 6 (–3, 15) .187
Mental health 75  15 88  11 –13 (–22, –4) .004
Social functioning 88  14 96  14 –7 (–15, 1) .066
tabLe 6
Correlation Coefficient (Spearman Rho) Between 
Body Function and Activity Components
Abbreviations: 6MWT, 6-minute walk test; ICF, International Classification of Functioning, Dis-
ability and Health framework; ROM, range of motion; SF-36, 36-item short-form health survey; VAS, 
visual analogue scale; WOMAC, Western Ontario and McMaster University Osteoarthritis Index.
* Significant (P.01).
† Significant (P.05).
 Physical Function Physical Walking 
iCF, body Functions (WoMaC) Function (sF-36) distance (6MWt)
Muscle strength   
 Knee extension –0.14 0.36 0.57*
 Knee flexion –0.11 0.18 0.48*
 Ankle dorsiflexion –0.08 0.24 0.58*
 Ankle plantar flexion –0.26 0.24 0.64*
 Hip extension –0.09 0.18 0.57*
 Hip flexion –0.21 0.39 0.58*
Hip ROM   
 Extension –0.33 0.21 0.03
 Flexion –0.64* 0.20 0.52*
 Abduction –0.44† 0.24 0.24
 Adduction –0.08 0.09 0.28
 Internal rotation –0.29 0.37 0.06
 External rotation 0.03 0.14 0.25
Stiffness WOMAC stiffness 0.81* –0.22 –0.49*
Pain WOMAC pain 0.67* –0.37 –0.25
Pain while walking (VAS) 0.44† –0.51* –0.28
Aerobic capacity Astrand cycle test 0.12 –0.23 0.11
iCF, activity
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The results of this study provide fur-
ther evidence that even patients with 
mild to moderate pain related to hip OA 
have significant impairments and activ-
ity limitations that reduce function and 
increase disability. The knowledge of 
function and disability for patients with 
hip OA, with mild to moderate pain, may 
help clinicians to evaluate and develop 
rehabilitation programs aimed at im-
proving functioning and disability for this 
population. Targeting impairments early, 
preventing loss of function, and reducing 
lifetime disability in patients with OA has 
been listed among the leading health pri-
orities in the United States.21 Because the 
criteria for THR surgery mainly are based 
on the patient’s symptom state, better-
targeted rehabilitation might in the long 




he present study showed that 
patients with hip OA, with mild to 
moderate pain, have significantly 
lower knee extension muscle strength, 
less hip ROM, and shorter walking dis-
tance compared to a matched control 
group. The impairments of body func-
tions in this study were associated with 
activity limitations, suggesting that 
impairments of body function should 
be targeted during rehabilitation of pa-
tients with hip OA.9,43 t
 Key Points
Findings: Patients with hip OA and mild 
to moderate pain had significantly lower 
knee extension strength, less hip ROM, 
and shorter walking distance during the 
6MWT compared to a matched control 
group.
iMPLiCation: Rehabilitation programs 
should consider including quadriceps 
muscle strength training and hip ROM 
exercises to improve function and dis-
ability in this population.
CaUtion: The results of this study may 
not apply to individuals with either less- 
or more-severe hip OA.
with hip OA. The nonsignificant associa-
tion between muscle strength and self-
reported activity in our study might be 
a consequence of a small sample size (n 
= 26). Furthermore, we found that hip 
abduction and flexion ROM were associ-
ated with WOMAC physical function (ρ = 
–0.44 and –0.64), and hip flexion ROM 
was associated with walking distance (ρ 
= 0.52). Stiffness, as measured by the 
WOMAC, was associated with walking 
distance and WOMAC physical function 
(ρ = 0.49 and 0.80, respectively). Re-
duced hip ROM and increased stiffness 
in patients with hip OA may, therefore, 
have an impact on their functioning and 
disability, such as putting on socks, get-
ting in and out of a car, or picking some-
thing up from the floor. Pain measured 
with the WOMAC was associated with 
physical function measured with the 
WOMAC, and pain perceived while walk-
ing was associated with physical function 
measured with the WOMAC and the SF-
36. Because the 2 pain measures were as-
sociated with physical function measured 
with the WOMAC but not to the 6MWT 
or with the SF-36 physical functioning 
score, the result of pain and its associa-
tion to physical function is ambiguous. 
Hence, no conclusions of the associa-
tion of pain and physical function can be 
drawn from this study.
Some limitations of this present study 
need to be discussed. The subjects in the 
control group did not undergo radiologi-
cal examination of the hip joint before in-
clusion. We, therefore, cannot completely 
rule out radiographic signs of hip joint 
OA for those subjects. We used a cut-off 
below 60 points on the HHS as the cri-
terion to be a candidate for hip surgery. 
There is no study that has investigated 
the cut-off of 60 points for surgery, but 
a preoperative HHS below 60 points has 
been found in several studies evaluating 
patients with hip OA for THR.11,24 Power 
calculations were based on knee exten-
sion muscle strength only, possibly re-
sulting in a lack of statistical power for 
some of the other variables measured in 
this study.
patients with hip OA who participated 
in these earlier studies had severe hip 
OA and might have had larger muscle 
strength deficits.40,44 Based on current 
evidence of lower knee extension muscle 
strength in patients with mild to moder-
ate hip OA, physical therapists should 
consider including quadriceps muscle 
strengthening exercises when developing 
rehabilitation programs.
Although the patients with hip OA 
in our study only had mild to moder-
ate pain, they had significantly lower 
hip ROM compared to the matched 
controls, except for adduction. These 
findings are consistent with previous 
studies.2,43 Hence, ROM deficits should 
be targeted during rehabilitation of pa-
tients with hip OA.
The patients with hip OA in our study 
covered a significantly shorter distance 
during the 6MWT (643 versus 719 m) 
compared to the controls. The patients 
with hip OA had significantly more 
hip pain compared to the controls dur-
ing walking (visual analog scale), which 
might have led to the shorter walking dis-
tance; although there was no significant 
difference in aerobic capacity between 
the groups. Two studies have shown sig-
nificantly reduced aerobic capacity in 
patients with severe hip and knee OA 
compared to controls.8,41 In our study, 
both the patients with mild to moderate 
hip OA and the controls showed average 
maximal aerobic capacity similar to nor-
mative data corrected for age (patients 
with hip OA, 28 ml/kg  min; controls, 
31 ml/kg  min; normative data, 27-35 
ml/kg  min).4
In this study, we found significant as-
sociations between body function and 
activity components. The primary find-
ing was that muscle strength was signifi-
cantly correlated with walking distance 
(ρ = 0.48 to 0.64); but we found no sig-
nificant association with the WOMAC 
physical function or SF-36 physical 
function outcome measures. In contrast, 
Pua et al39 found a significant association 
between knee extension muscle strength 
and SF-36 physical function in patients 
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